1. Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database. Issue 5 (May 2016) Authors: Wolff, I.; May, M.; Hoschke, B.; Zigeuner, R.; Cindolo, L.; Hutterer, G.; Schips, L.; De Cobelli, O.; Rocco, B.; De Nunzio, C.; Tubaro, A.; Coman, I.; Feciche, B.; Truss, M.; Dalpiaz, O.; Figenshau, R.S.; Madison, K.; Sánchez-Chapado, M.; Santiago Martin, M.D.C.; Salzano, L. Journal: European journal of surgical oncology Issue: Volume 42:Issue 5(2016:May) Page Start: 744 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of off‐label use regulations on patient care in dermatology – a prospective study of cost‐coverage applications filed by tertiary dermatology clinics throughout Germany. (7th July 2022) Authors: Werner, R.N.; Pennitz, A.; Eisert, L.; Schmidle, P.; Zink, A.; Abraham, S.; Schäkel, K.; Wolff, I.; Goebeler, M.; Plange, J.; Sollfrank, L.; Zielbauer, S.; Koll, P.; Amschler, K.; Müller, V.; Nast, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 11(2022) Page Start: 2241 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗